Statins are independently associated with reduced mortality in patients undergoing infrainguinal bypass graft surgery for critical limb ischemia

Journal of Vascular Surgery

Volumn 47, Issue 4, 2008, Pages

  Schanzer, Andres ^a   Hevelone, Nathanael ^b   Owens, Christopher D ^b   Beckman, Joshua A ^b   Belkin, Michael ^b   Conte, Michael S ^b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; EDIFOLIGIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; ARTERY DISEASE; ARTICLE; BYPASS SURGERY; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; COHORT ANALYSIS; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEMOGRAPHY; DRUG EFFICACY; DRUG USE; ENGINEERING; EX VIVO STUDY; FEMALE; GRAFT FAILURE; HAZARD RATIO; HUMAN; INFRAINGUINAL BYPASS GRAFT; INGUINAL REGION; KAPLAN MEIER METHOD; LEG; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MEDICAL LITERATURE; MORTALITY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; POPULATION; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; SURVIVAL; VEIN GRAFT;

EID: 41249085128     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2007.11.056     Document Type: Article

References (44)

1. Criqui M.H., Fronek A., Barrett-Connor E., Klauber M.R., Gabriel S., and Goodman D. The prevalence of peripheral arterial disease in a defined population. Circulation 71 (1985) 510-515
2. Meijer W.T., Hoes A.W., Rutgers D., Bots M.L., Hofman A., and Grobbee D.E. Peripheral arterial disease in the elderly: The Rotterdam Study. Arterioscler Thromb Vasc Biol 18 (1998) 185-192
3. Selvin E., and Erlinger T.P. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 110 (2004) 738-743
4. Murabito J.M., Evans J.C., Nieto K., Larson M.G., Levy D., and Wilson P.W. Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study. Am Heart J 143 (2002) 961-965
5. Diehm C., Schuster A., Allenberg J.R., Darius H., Haberl R., Lange S., et al. High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study. Atherosclerosis 172 (2004) 95-105
6. Hirsch A.T., Criqui M.H., Treat-Jacobson D., Regensteiner J.G., Creager M.A., Olin J.W., et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 286 (2001) 1317-1324
7. Criqui M.H., Langer R.D., Fronek A., Feigelson H.S., Klauber M.R., McCann T.J., et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 326 (1992) 381-386
8. McKenna M., Wolfson S., and Kuller L. The ratio of ankle and arm arterial pressure as an independent predictor of mortality. Atherosclerosis 87 (1991) 119-128
9. Howell M.A., Colgan M.P., Seeger R.W., Ramsey D.E., and Sumner D.S. Relationship of severity of lower limb peripheral vascular disease to mortality and morbidity: a six-year follow-up study. J Vasc Surg 9 (1989) 691-696 discussion 6-7
10. Caro J., Migliaccio-Walle K., Ishak K.J., and Proskorovsky I. The morbidity and mortality following a diagnosis of peripheral arterial disease: long-term follow-up of a large database. BMC Cardiovasc Disord 5 (2005) 14
11. McDermott M.M., Mehta S., Ahn H., and Greenland P. Atherosclerotic risk factors are less intensively treated in patients with peripheral arterial disease than in patients with coronary artery disease. J Gen Intern Med 12 (1997) 209-215
12. Mukherjee D., Lingam P., Chetcuti S., Grossman P.M., Moscucci M., Luciano A.E., et al. Missed opportunities to treat atherosclerosis in patients undergoing peripheral vascular interventions: insights from the University of Michigan Peripheral Vascular Disease Quality Improvement Initiative (PVD-QI2). Circulation 106 (2002) 1909-1912
13. Mehta S.R., Yusuf S., Peters R.J., Bertrand M.E., Lewis B.S., Natarajan M.K., et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 358 (2001) 527-533
14. Pearson T.A., McBride P.E., Miller N.H., and Smith S.C. 27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 8. Organization of preventive cardiology service. J Am Coll Cardiol 27 (1996) 1039-1047
15. Smith Jr. S.C., Blair S.N., Criqui M.H., Fletcher G.F., Fuster V., Gersh B.J., et al. AHA consensus panel statement. Preventing heart attack and death in patients with coronary disease. The Secondary Prevention Panel. J Am Coll Cardiol 26 (1995) 292-294
16. Hirsch A.T., Haskal Z.J., Hertzer N.R., Bakal C.W., Creager M.A., Halperin J.L., et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol 47 (2006) 1239-1312
17. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360 (2002) 7-22
18. Feringa H.H., Karagiannis S.E., van Waning V.H., Boersma E., Schouten O., Bax J.J., et al. The effect of intensified lipid-lowering therapy on long-term prognosis in patients with peripheral arterial disease. J Vasc Surg 45 (2007) 936-943
19. Schillinger M., Exner M., Mlekusch W., Amighi J., Sabeti S., Muellner M., et al. Statin therapy improves cardiovascular outcome of patients with peripheral artery disease. Eur Heart J 25 (2004) 742-748
20. Collaborative overview of randomised trials of antiplatelet therapy-I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration. BMJ 308 (1994) 81-106
21. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324 (2002) 71-86
22. Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions. J Vasc Surg 45 (2007) 645-654 discussion 53-4.
23. Kertai M.D., Boersma E., Westerhout C.M., van Domburg R., Klein J., Bax J.J., et al. Association between long-term statin use and mortality after successful abdominal aortic aneurysm surgery. Am J Med 116 (2004) 96-103
24. Poldermans D., Boersma E., Bax J.J., Thomson I.R., van de Ven L.L., Blankensteijn J.D., et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 341 (1999) 1789-1794
25. Poldermans D., Bax J.J., Kertai M.D., Krenning B., Westerhout C.M., Schinkel A.F., et al. Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation 107 (2003) 1848-1851
26. O'Neil-Callahan K., Katsimaglis G., Tepper M.R., Ryan J., Mosby C., Ioannidis J.P., et al. Statins decrease perioperative cardiac complications in patients undergoing noncardiac vascular surgery: the Statins for Risk Reduction in Surgery (StaRRS) study. J Am Coll Cardiol 45 (2005) 336-342
27. Abbruzzese T.A., Havens J., Belkin M., Donaldson M.C., Whittemore A.D., Liao J.K., et al. Statin therapy is associated with improved patency of autogenous infrainguinal bypass grafts. J Vasc Surg 39 (2004) 1178-1185
28. Collaborative overview of randomised trials of antiplatelet therapy-II: Maintenance of vascular graft or arterial patency by antiplatelet therapy. Antiplatelet Trialists' Collaboration. BMJ 308 (1994) 159-168
29. Henke P.K., Blackburn S., Proctor M.C., Stevens J., Mukherjee D., Rajagopalin S., et al. Patients undergoing infrainguinal bypass to treat atherosclerotic vascular disease are underprescribed cardioprotective medications: effect on graft patency, limb salvage, and mortality. J Vasc Surg 39 (2004) 357-365
30. Conte M.S., Bandyk D.F., Clowes A.W., Moneta G.L., Seely L., Lorenz T.J., et al. Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery. J Vasc Surg 43 (2006) 742-751 discussion 51
31. Conte M.S., Lorenz T.J., Bandyk D.F., Clowes A.W., Moneta G.L., and Seely B.L. Design and rationale of the PREVENT III clinical trial: edifoligide for the prevention of infrainguinal vein graft failure. Vasc Endovascular Surg 39 (2005) 15-23
32. Rutherford R.B., Baker J.D., Ernst C., Johnston K.W., Porter J.M., Ahn S., et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 26 (1997) 517-538
33. Rosenbaum P.R.D. The central role of the propensity score in observational studies for causal effects. Biometrika (1983) 41-55
34. Dormandy J.A., and Rutherford R.B. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 31 (2000) S1-S296
35. Conte M.S., Bandyk D.F., Clowes A.W., Moneta G.L., Namini H., and Seely L. Risk factors, medical therapies and perioperative events in limb salvage surgery: observations from the PREVENT III multicenter trial. J Vasc Surg 42 (2005) 456-464 discussion 64-5
36. Ward R.P., Leeper N.J., Kirkpatrick J.N., Lang R.M., Sorrentino M.J., and Williams K.A. The effect of preoperative statin therapy on cardiovascular outcomes in patients undergoing infrainguinal vascular surgery. Int J Cardiol 104 (2005) 264-268
37. Mangano D.T., Layug E.L., Wallace A., and Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med 335 (1996) 1713-1720
38. Kertai M.D., Boersma E., Westerhout C.M., Klein J., Van Urk H., Bax J.J., et al. A combination of statins and beta-blockers is independently associated with a reduction in the incidence of perioperative mortality and nonfatal myocardial infarction in patients undergoing abdominal aortic aneurysm surgery. Eur J Vasc Endovasc Surg 28 (2004) 343-352
39. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348 (1996) 1329-1339
40. Rubin D.B. Estimating causal effects from large data sets using propensity scores. Ann Intern Med 127 (1997) 757-763
41. Cepeda M.S., Boston R., Farrar J.T., and Strom B.L. Comparison of logistic regression versus propensity score when the number of events is low and there are multiple confounders. Am J Epidemiol 158 (2003) 280-287
42. Eagle K.A., Berger P.B., Calkins H., Chaitman B.R., Ewy G.A., Fleischmann K.E., et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery-executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation 105 (2002) 1257-1267
43. Christenson J. Preoperative lipid control with simvastatin reduces the risk for graft failure already 1 year after myocardial revascularization. Cardiovasc Surg 9 (2001) 33-43
44. Owens C.D., Ridker P.M., Belkin M., Hamdan A.D., Pomposelli F., Logerfo F., et al. Elevated C-reactive protein levels are associated with postoperative events in patients undergoing lower extremity vein bypass surgery. J Vasc Surg 45 (2007) 2-9 discussion 9